利润表
SALARIUS PHARMACEUTICALS, INC.
DCOY
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | 0.00 | 1.84 | 5.23 | 3.47 | 0.84 | 1.27 | 1.01 | - | - |
|
营业成本
|
- | - | - | - | - | - | - | 0.43 | - | - | - | - |
|
毛利润
|
- | - | - | - | 1.84 | 5.23 | 3.47 | 0.41 | 1.27 | 1.01 | - | - |
|
营业费用
|
12.61 | 5.73 | 12.89 | 31.84 | 14.65 | 13.02 | 11.73 | 22.91 | 36.00 | 40.90 | 29.21 | 0.00 |
|
研发费用
|
0.37 | 0.77 | 7.17 | 15.84 | 8.55 | 6.91 | 4.02 | 11.91 | 16.99 | 20.38 | 12.75 | - |
|
销售、一般及行政费用
|
3.73 | 4.96 | 5.72 | 7.14 | 6.10 | 6.11 | 7.71 | 10.57 | 18.50 | 19.86 | 16.46 | - |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-12.61 | -5.73 | -12.89 | -31.84 | -12.81 | -7.79 | -8.27 | -22.50 | -34.73 | -39.89 | -29.21 | - |
|
营业外收入
|
- | - | - | - | - | - | - | - | - | - | 0.00 | - |
|
利息收入
|
- | - | - | - | - | - | - | 0.15 | 0.29 | 0.39 | 0.07 | - |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
税前利润
|
- | - | - | - | - | - | - | - | - | - | -29.21 | - |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | -0.07 | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-12.52 | -5.58 | -12.54 | -31.61 | -12.77 | -7.35 | -6.94 | -21.92 | -34.43 | -39.49 | -29.14 | - |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-12.61 | -5.73 | -12.88 | -31.83 | -12.79 | -7.77 | -8.14 | -22.50 | -34.73 | -39.89 | -29.21 | 0.00 |
|
基本每股收益
|
-129.10 | -5.79 | -3.84 | -14.88 | -0.31 | - | - | - | - | - | - | - |
|
稀释每股收益
|
-129.10 | -5.79 | -3.84 | -14.88 | -0.31 | - | - | - | - | - | - | - |
|
加权平均股数
|
0.10 | 0.96 | 3.26 | 2.12 | 41.37 | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
0.10 | 0.96 | 3.26 | 2.12 | 41.37 | - | - | - | - | - | - | - |
|
综合收益
|
- | - | - | - | - | - | - | -21.92 | -34.43 | -39.47 | -29.17 | - |